Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,494 | -4,074 | -3,331 | -2,318 | -1,113 |
| Depreciation Amortization | 92 | 436 | 342 | 231 | 96 |
| Accounts payable and accrued liabilities | 313 | 269 | 498 | 148 | -89 |
| Other Working Capital | 550 | 432 | 857 | 322 | -42 |
| Other Operating Activity | 146 | 126 | -61 | 196 | 298 |
| Operating Cash Flow | $-394 | $-2,811 | $-1,695 | $-1,421 | $-850 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 14 | 14 | -18 | -7 |
| Investing Cash Flow | $N/A | $14 | $14 | $-18 | $-7 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 101 | 2,963 | 1,888 | 1,638 | 1,438 |
| Debt Repayment | -50 | -308 | -210 | N/A | -93 |
| Common Stock Issued | 275 | 200 | N/A | -210 | N/A |
| Common Stock Repurchased | N/A | -4 | N/A | N/A | N/A |
| Financing Cash Flow | $326 | $2,850 | $1,678 | $1,428 | $1,345 |
| Beginning Cash Position | 72 | 18 | 18 | 18 | 18 |
| End Cash Position | 3 | 72 | 15 | 7 | 506 |
| Net Cash Flow | $-68 | $53 | $-4 | $-11 | $488 |
| Free Cash Flow | |||||
| Operating Cash Flow | -394 | -2,811 | -1,695 | -1,421 | -850 |
| Capital Expenditure | N/A | -18 | -18 | -18 | -7 |
| Free Cash Flow | -394 | -2,829 | -1,713 | -1,439 | -857 |